CKD患者30天非计划再入院或死亡风险的人群队列研究
该研究基于加拿大阿尔伯塔省2005至2021年住院成人数据,按eGFR分为八组,评估eGFR与出院后30天内非计划再入院或死亡的关联。结果显示eGFR越低,风险越高,肾移植受者组和未透析G5组调整OR最高。心衰是最常见再入院诊断,其次为AKI。
要点
- eGFR降低与30天非计划再入院或死亡风险升高独立相关。
- 肾移植受者和未透析G5患者调整OR最高,分别达1.47和1.40。
- 心衰是低eGFR组最常见再入院诊断,其次为AKI。
核心结论
- 严重CKD患者出院后30天非计划再入院或死亡风险最高,需针对容量和血流动力学相关再入院(如出院后AKI和心衰)测试干预措施。
研究设计与样本
- 基于加拿大阿尔伯塔省2005至2021年住院成人的人群队列研究,共纳入1,249,248名参与者的2,992,810次住院。
- 按入院前eGFR分为八组:G1-2(≥60)、G3a(45-59)、G3b(30-44)、G4(15-29)、G5ND(<15未透析)、G5D(透析)、G1T-5T(肾移植受者)和未知组,单位为ml/min per 1.73 m²。
- 主要结局为出院后30天内非计划再入院或死亡,采用多变量logistic回归估计调整OR,以G1-2为参照,并按年龄和性别分层。
主要发现
- 中位年龄61岁(IQR 47-74),中位每人住院次数1次(IQR 1-3)。
- 与G1-2相比,eGFR受损更严重的组主要结局调整OR显著更高,最高为G1T-5T组(aOR 1.47;95%CI 1.12-1.93)和G5ND组(aOR 1.40;95%CI 1.34-1.47)。
- 在较低eGFR类别中,心衰是最常见再入院诊断,其次为AKI。
- 分层分析显示,65岁以下和女性eGFR降低者相比G1-2参照组对应人群调整OR更高。
临床怎么用
- 对严重CKD患者出院时应实施基于风险的分层出院策略,重点监测容量和血流动力学相关再入院风险。
- 针对心衰和出院后AKI高发特点,可考虑在出院后早期加强随访和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: People with CKD are at high risk of unplanned readmission and death due to multimorbidity and health care complexity. Lower eGFR is strongly associated with 30-day unplanned readmission or death, with congestive heart failure as the most common cause. Targeted, risk-based discharge strategies are needed to reduce readmissions and improve outcomes in CKD populations. BACKGROUND: People with CKD have higher risk of repeated hospitalization and mortality than the general population. Given many unplanned readmissions may be avoidable, examining risks and reasons for readmission across CKD categories may inform targeted interventions and safer discharge planning. Thus, we estimated the association between eGFR and both readmission and mortality and identified diagnoses for readmission. METHODS: Adults discharged from hospitals in Alberta, Canada, from 2005 to 2021 were included. Preadmission eGFR was categorized into eight groups (in ml/min per 1.73 m 2 ): ≥60 (G1-2), 45-59 (G3a), 30-44 (G3b), 15-29 (G4), <15 not on dialysis (G5ND), on dialysis (G5D), prevalent kidney transplant recipients (G1T-5T), and unknown. The primary outcome was unplanned readmission or death within 30 days of discharge. Multivariable logistic regression, accounting for multiple admissions per participant, was used to estimate unadjusted and adjusted odds ratios (aOR) of the primary outcome, using G1-2 as the reference. The results were stratified by age and sex. The type and frequency of each unplanned readmission was also determined. RESULTS: The cohort comprised 2,992,810 admissions among 1,249,248 participants (median [interquartile range] admission per participant: 1 [1-3] admission; age: 61 [47-74] years). Among lower eGFR categories, heart failure was the most common readmission diagnosis, followed by AKI. Relative to G1-2, more impaired eGFR groups had significantly higher odds of the primary outcome, with the highest adjusted odds experienced by the G1T-5T group (aOR, 1.47; 95% confidence interval, 1.12 to 1.93) and G5ND group (aOR, 1.40; 95% confidence interval, 1.34 to 1.47). Stratified analyses showed that individuals younger than 65 years and females with reduced eGFR had higher odds compared with counterparts in the G1-2 reference group. CONCLUSIONS: People with severe CKD had the highest risk of hospital readmission, suggesting the need to test interventions in this group to target volume and hemodynamic related readmissions such as postdischarge AKI and heart failure.
引用
- Pattar BSB, Sevinc E, Scory TD, et al. Risk of Hospital Readmission among People with CKD: A Population-Based Cohort Study. Clin J Am Soc Nephrol. 2026. PMID: 42028641. doi:10.2215/CJN.0000001032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。